title: TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy.
abstract: OBJECTIVE
  Proliferative diabetic retinopathy (PDR) results from the formation of fibrovascular membranes (FVMs) in the posterior fundus that can lead to a severe decrease of vision. Tumor endothelial marker 7 (TEM7) is a protein that is highly expressed in the endothelial cells of tumors, but whether it plays a role in FVMs is unknown. The purpose of this study was to determine whether TEM7 is associated with the formation of FVMs.
  
  
  METHODS
  FVMs were obtained during vitrectomy from patients with PDR. RT-PCR was performed to determine the level of expression of the mRNA of TEM7. The splice variants of TEM7 were identified by direct sequencing. Immunohistochemical analyses and in situ hybridization was performed to determine the sites of TEM7 in the FVMs.
  
  
  RESULTS
  The level of the mRNA of TEM7 was high in 10 of 10 FVMs but was barely detectable in the five idiopathic epiretinal membranes. Direct sequencing of subcloned TEM7 PCR products revealed several splice variants (intracellular, secreted, and membrane-bound forms of TEM7) in the FVMs. Immunohistochemical analysis showed a colocalization of TEM7 and CD34, an endothelial cell marker, in most of the neovascular endothelial cells in the FVMs. Immunoelectron microscopy revealed that membrane-bound TEM7 was expressed on the luminal surfaces of the vascular endothelial cells of FVMs.
  
  
  CONCLUSIONS
  This study indicates that TEM7 may play a significant role in the proliferation and maintenance of neovascular endothelial cells in the FVMs. If correct, TEM7 may be a molecular target for new diagnostic and therapeutic strategies for PDR.
authors.affiliation: Department of Ophthalmology, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
authors.forename: Yoko
authors.initials: Y
authors.lastname: Yamaji
authors.forename: Shigeo
authors.initials: S
authors.lastname: Yoshida
authors.forename: Keijiro
authors.initials: K
authors.lastname: Ishikawa
authors.forename: Akihito
authors.initials: A
authors.lastname: Sengoku
authors.forename: Kota
authors.initials: K
authors.lastname: Sato
authors.forename: Ayako
authors.initials: A
authors.lastname: Yoshida
authors.forename: Rumi
authors.initials: R
authors.lastname: Kuwahara
authors.forename: Kenoki
authors.initials: K
authors.lastname: Ohuchida
authors.forename: Eiji
authors.initials: E
authors.lastname: Oki
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Enaida
authors.forename: Kimihiko
authors.initials: K
authors.lastname: Fujisawa
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Kono
authors.forename: Tatsuro
authors.initials: T
authors.lastname: Ishibashi
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D003930:Diabetic Retinopathy / Q000378:metabolism*; D004195:Disease Models, Animal; D042783:Endothelial Cells / Q000378:metabolism*; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism*; D020033:Protein Isoforms / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000235:genetics / Q000378:metabolism*; D015861:Retinal Neovascularization / Q000209:etiology* / Q000378:metabolism*; D014018:Tissue Distribution
chemical_list: D009363:Neoplasm Proteins; C510620:PLXDC1 protein, human; D020033:Protein Isoforms; D012333:RNA, Messenger; D011956:Receptors, Cell Surface